Comparative Safety and Efficacy of Modified TICI 2b and TICI 3 Reperfusion in Acute Ischemic Strokes Treated With Mechanical Thrombectomy.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 30 08 2017
accepted: 06 03 2018
pubmed: 5 4 2018
medline: 2 1 2020
entrez: 5 4 2018
Statut: ppublish

Résumé

Mechanical thrombectomy (MT) is the current standard of care for acute ischemic stroke (AIS) patients with emergent large-vessel occlusions (ELVO). Successful reperfusion of ELVO is traditionally defined by modified Thrombolysis in Cerebral Infarction (mTICI) grades of 2b or 3. To evaluate the comparative safety and efficacy of mTICI 2b and mTICI 3 reperfusion in AIS patients treated with MT. Consecutive ELVO patients who underwent MT at 6 high-volume centers were included in this analysis. Standard safety (3-mo mortality, symptomatic intracranial hemorrhage [sICH]) and efficacy (absolute and relative reduction in NIHSS-scores during hospitalization, functional-improvement [shift analysis in mRS-scores], and functional-independence [mRS-scores of 0-2] at 3-mo) were compared between patients who had mTICI 2b and mTICI 3 reperfusion post MT. A total of 416 ELVO patients achieved successful reperfusion with mTICI 2b (n = 216) and mTICI 3 (n = 200) following MT. The mTICI 3 group had significantly (P < .05) greater absolute (11 vs 9 points) and relative (77% vs 63%) reduction in NIHSS-scores during hospitalization, lower sICH (6% vs 12%), and higher 3-mo functional-independence (55% vs 44%) rates. Successful reperfusion with mTICI 3 was independently (P < .05) associated with greater absolute and relative reduction in NIHSS-scores during hospitalization as well as higher odds of 3-mo functional improvement (common odds ratios: 1.67; 95% confidence interval: 1.10-2.56) and functional independence (odds ratio: 2.08; 95% confidence interval: 1.22-3.53) in multivariable regression models adjusting for confounders. Successful reperfusion with mTICI 3 was associated with greater neurological improvement during hospitalization and better 3-mo functional outcomes in comparison to mTICI 2b reperfusion.

Sections du résumé

BACKGROUND
Mechanical thrombectomy (MT) is the current standard of care for acute ischemic stroke (AIS) patients with emergent large-vessel occlusions (ELVO). Successful reperfusion of ELVO is traditionally defined by modified Thrombolysis in Cerebral Infarction (mTICI) grades of 2b or 3.
OBJECTIVE
To evaluate the comparative safety and efficacy of mTICI 2b and mTICI 3 reperfusion in AIS patients treated with MT.
METHODS
Consecutive ELVO patients who underwent MT at 6 high-volume centers were included in this analysis. Standard safety (3-mo mortality, symptomatic intracranial hemorrhage [sICH]) and efficacy (absolute and relative reduction in NIHSS-scores during hospitalization, functional-improvement [shift analysis in mRS-scores], and functional-independence [mRS-scores of 0-2] at 3-mo) were compared between patients who had mTICI 2b and mTICI 3 reperfusion post MT.
RESULTS
A total of 416 ELVO patients achieved successful reperfusion with mTICI 2b (n = 216) and mTICI 3 (n = 200) following MT. The mTICI 3 group had significantly (P < .05) greater absolute (11 vs 9 points) and relative (77% vs 63%) reduction in NIHSS-scores during hospitalization, lower sICH (6% vs 12%), and higher 3-mo functional-independence (55% vs 44%) rates. Successful reperfusion with mTICI 3 was independently (P < .05) associated with greater absolute and relative reduction in NIHSS-scores during hospitalization as well as higher odds of 3-mo functional improvement (common odds ratios: 1.67; 95% confidence interval: 1.10-2.56) and functional independence (odds ratio: 2.08; 95% confidence interval: 1.22-3.53) in multivariable regression models adjusting for confounders.
CONCLUSION
Successful reperfusion with mTICI 3 was associated with greater neurological improvement during hospitalization and better 3-mo functional outcomes in comparison to mTICI 2b reperfusion.

Identifiants

pubmed: 29618102
pii: 4957034
doi: 10.1093/neuros/nyy097
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

680-686

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2018 by the Congress of Neurological Surgeons.

Auteurs

Nitin Goyal (N)

Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.

Georgios Tsivgoulis (G)

Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.
Second Department of Neurology, "Attikon University Hospital," School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Donald Frei (D)

Department of Interventional Neuroradiology, Radiology Imaging Associates, Englewood, Colorado.

Aquilla Turk (A)

Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina.

Blaise Baxter (B)

Department of Interventional Neuroradiology, Erlanger Hospital, Chattanooga, Tennessee.

Michael T Froehler (MT)

Cerebrovascular Program, Vanderbilt University, Nashville, Tennessee.

J Mocco (J)

Department of Neurosurgery, Mount Sinai Medical Center, New York, New York.

Muhammad Fawad Ishfaq (MF)

Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.

Konark Malhotra (K)

Department of Neurology, West Virginia University Charleston Division, Charleston, West Virginia.

Jason J Chang (JJ)

Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.

Daniel Hoit (D)

Department of Neurosurgery, University of Tennessee Health Science Center and Semmes-Murphey Clinic, Memphis, Tennessee.

Lucas Elijovich (L)

Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.
Department of Neurosurgery, University of Tennessee Health Science Center and Semmes-Murphey Clinic, Memphis, Tennessee.

David Loy (D)

Department of Interventional Neuroradiology, Radiology Imaging Associates, Englewood, Colorado.

Raymond D Turner (RD)

Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina.

Justin Mascitelli (J)

Department of Neurosurgery, Mount Sinai Medical Center, New York, New York.

Kiersten Espaillat (K)

Cerebrovascular Program, Vanderbilt University, Nashville, Tennessee.

Andrei V Alexandrov (AV)

Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee.

Adam S Arthur (AS)

Department of Neurosurgery, University of Tennessee Health Science Center and Semmes-Murphey Clinic, Memphis, Tennessee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH